Another box ticked. Not much pomp & ceremony from these blokes but they are making the progress that they have undertaken to.SP is underperforming, no doubt about that, but behind the scenes the progress seems to be perfectly on track.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%